Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies.
Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies.
复制标题
DOI:
10.1016/j.bios.2017.06.030
复制
发表时间:
2017-12-15
影响因子:
12.6
通讯作者:
Govindaraju T
中科院分区:
文献类型:
--
作者:
Rajasekhar K;Narayanaswamy N;Murugan NA;Viccaro K;Lee HG;Shah K;Govindaraju T
Selective detection and staining of toxic amyloid plaques, a potential biomarker present in the Alzheimer’s disease (AD) brain is crucial for both clinical diagnosis and monitoring AD disease progression. Herein, we report a coumarin-quinoline (CQ) conjugate-based turn-on near-infrared (NIR) fluorescence probe for specific detection of β-amyloid (Aβ) aggregates. CQ probe is highly sensitive and exhibits ~100-fold fluorescence enhancement in vitro upon binding Aβ aggregates with enhanced quantum yield. Furthermore, the probe has ~10-fold higher binding affinity towards Aβ aggregates (86 nM) compared to commonly used Thioflavin T. Most importantly, CQ probe displays unambiguous selectivity towards Aβ aggregates compared to other toxic protein aggregates such as tau, α-synuclein (α-Syn) and islet amyloid polypeptide (IAPP). In addition, CQ is nontoxic to neuronal cells and shows significant blood brain barrier permeability. Remarkably, CQ stains Aβ plaques in human brain tissue over co-existing tau aggregates and neurofibrillary tangles (NFTs), which are associated in AD and tauopathies. This is a highly desirable attribute to distinguish AD from tau pathology and mixed dementia.
登录
查看更多内容
影响因子:
8.4
作者:
Han X;Yu F;Song X;Chen L
通讯作者:
Chen L
影响因子:
46.2
作者:
DeToma AS;Salamekh S;Ramamoorthy A;Lim MH
通讯作者:
Lim MH
影响因子:
14.9
作者:
Narayanaswamy N;Das S;Samanta PK;Banu K;Sharma GP;Mondal N;Dhar SK;Pati SK;Govindaraju T
通讯作者:
Govindaraju T
影响因子:
4.6
作者:
Rajasekhar K;Narayanaswamy N;Murugan NA;Kuang G;Ågren H;Govindaraju T
通讯作者:
Govindaraju T
影响因子:
5
作者:
Rajasekhar, K.;Madhu, Chilakapati;Govindaraju, T.
通讯作者:
Govindaraju, T.